Evommune, Inc. (EVMN)

NYQ – Real Time Price. Currency in USD

22.69

-0.52 (-2.24%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

Total Revenue

13M

Cost of goods sold

-1M

Gross Profit

12M

Operating expenses (excl. COGS)

-93M

-76M

-42M

Operating Income

-81M

-70M

-38M

Non-operating income, total

12M

Pretax income

-69M

-67M

-34M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-69M

-67M

-34M

Evommune, Inc. (EVMN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Evommune, Inc. (EVMN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Evommune, Inc. (EVMN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Evommune, Inc. (EVMN)

Income Statement (Annual)

Income Statement (Annual)